Breaking News
1 day ago
Vaibhavi M.

WHO projects cancer cases to reach 35 million annually by 2050, with direct implications for oncology manufacturing capacity and regulatory readiness.
Vaibhavi M.

FibroBiologics appoints retired NASA astronaut and microbiologist Kate Rubins, Ph.D. to its Board of Directors, elevating her from Scientific Advisory Board.
Vaibhavi M.

Teva and Polpharma Biologics split CMC and regulatory roles in a global licensing deal for an ocrelizumab biosimilar candidate across eight markets.
Vaibhavi M.

Novo Nordisk launches Awiqli in India, the world's first once-weekly basal insulin, at Rs. 2,611 per pen, raising cold chain and fill-finish validation questions.
Vaibhavi M.
